| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $55.5M | — | +2.6% |
| Cost of Revenue | $34.4M | — | +9.0% |
| R&D Expense | $38.5M | — | -8.5% |
| SG&A Expense | $21.4M | — | +10.6% |
| Operating Income | -$38.9M | — | +0.2% |
| Interest Expense | $4.3M | — | -3.8% |
| Pre-tax Income | -$47.4M | — | -27.8% |
| Income Tax | -$319K | — | -669.6% |
| Net Income | -$43.2M | — | -25.0% |
| EPS (Basic) | -$0.21 | — | -16.7% |
| EPS (Diluted) | -$0.21 | — | -16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $174.4M | +19.9% | -26.3% |
| Accounts Receivable | $60.5M | +5.2% | -3.8% |
| Inventory | $57.0M | +17.3% | +19.3% |
| Current Assets | $327.2M | +14.5% | -14.3% |
| Total Assets | $869.6M | +3.4% | -4.3% |
| Current Liabilities | $79.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | +23.7% |
| Capital Expenditures | $3.2M | — | +35.1% |
| Investing Cash Flow | -$3.2M | — | -35.1% |
| Financing Cash Flow | $55.1M | — | +1261.7% |
| Free Cash Flow | -$25.3M | — | +19.3% |
| +10.6% |
| Long-term Debt | $415.1M | +17.5% | +9.5% |
| Total Liabilities | $520.6M | +14.0% | +9.1% |
| Stockholders' Equity | $324.6M | -9.3% | -20.0% |